DeutschNewstral
Article
The Times of India on 2021-10-12 10:28
Expert panel approves Covaxin for children between 2-18 years
Related news
- Expert panel recommends approving Covaxin for kidsThe Times of India
- DCGI approves Covaxin for children above 12 yearsThe Times of India
Covaxin: Expert panel recommends emergency use approval for 2-18 year oldsThe Hindu- CDSCO expert panel recommends nod to study on mixing doses of Covaxin, CovishieldThe Hindu
- Coronavirus | Central panel recommends approval for CovaxinThe Hindu
- WHO panel to decide on Covaxin EUL tomorrowThe Times of India
- Corbevax, Covaxin get drug regulator nod for use in childrenThe Hindu
- Covaxin for children: recommendations being studied, says MinisterThe Hindu
- More data on Covaxin jabs for children soughtThe Hindu
- Coronavirus | Covaxin gets central drugs authority panel approval for restricted useThe Hindu
- Drug Controller General approves Covishield and Covaxin in India for ‘emergency use’The Hindu
- Covaxin demonstrates robust safety and immunogenicity in children 2-18 years: Bharat BiotechThe Hindu
- COVID-19 | AIIMS Delhi starts screening of children for Covaxin trialsThe Hindu
- Covaxin does not have WHO’s emergency use listing for use in childrenThe Hindu
- Covaxin safe for kids: Bharat BiotechThe Times of India
Expert panel approves criteria for probe into religious groupsThe Japan Times- WHO's approval for Covaxin likely this monthThe Times of India
- India can check pandemic by Feb-end: Expert panelThe Times of India
NAFDAC Approves Clinical Malaria Vaccine for Childrenthisdaylive.com